Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety

MLA

van den Hoogen, M. W. F., et al. “Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety.” American Journal of Transplantation, vol. 15, no. 2, Feb. 2015, pp. 407–16. EBSCOhost, https://doi.org/10.1111/ajt.13052.

APA

van den Hoogen, M. W. F., Kamburova, E. G., Baas, M. C., Steenbergen, E. J., Florquin, S., Koenen, H. J. P. M., Joosten, I., & Hilbrands, L. B. (2015). Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety. American Journal of Transplantation, 15(2), 407–416. https://doi.org/10.1111/ajt.13052

Chicago

van den Hoogen, M.W.F., E.G. Kamburova, M.C. Baas, E.J. Steenbergen, S. Florquin, H.J.P.M. Koenen, I. Joosten, and L.B. Hilbrands. 2015. “Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety.” American Journal of Transplantation 15 (2): 407–16. doi:10.1111/ajt.13052.